Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Abstract IA017: Iloprost for lung cancer prevention
View through CrossRef
Abstract
Iloprost is a prostacyclin analogue with anti-metastatic, vasodilatory and anti-inflammatory properties. Increased prostacyclin is protective in pre-clinical murine models of adenocarcinoma and squamous cell carcinoma (SCC), including tobacco smoke. The chemoprotective properties are independent of the single cell surface prostacyclin receptor, as knockout animals are still protected. Clinical studies of iloprost have included both oral and inhaled preparations. Oral iloprost improves endobronchial dysplasia (pre-cursor lesions for invasive SCC) in former smokers. Dysplastic lesions are now being characterized beyond histology to better understand lesion evolution. Investigations into the mechanism of iloprost associated cancer prevention (including effects on basal progenitor cells, progenitor multi-potentiality, and differentiation) and biomarkers predicting response will be presented, along with an outline for an upcoming clinical trial in former smokers.
Citation Format: Robert Keith. Iloprost for lung cancer prevention [abstract]. In: Proceedings of the Second Biennial NCI Meeting: Translational Advances in Cancer Prevention Agent Development (TACPAD); 2022 Sep 7-9. Philadelphia (PA): AACR; Can Prev Res 2022;15(12 Suppl_2): Abstract nr IA017.
Title: Abstract IA017: Iloprost for lung cancer prevention
Description:
Abstract
Iloprost is a prostacyclin analogue with anti-metastatic, vasodilatory and anti-inflammatory properties.
Increased prostacyclin is protective in pre-clinical murine models of adenocarcinoma and squamous cell carcinoma (SCC), including tobacco smoke.
The chemoprotective properties are independent of the single cell surface prostacyclin receptor, as knockout animals are still protected.
Clinical studies of iloprost have included both oral and inhaled preparations.
Oral iloprost improves endobronchial dysplasia (pre-cursor lesions for invasive SCC) in former smokers.
Dysplastic lesions are now being characterized beyond histology to better understand lesion evolution.
Investigations into the mechanism of iloprost associated cancer prevention (including effects on basal progenitor cells, progenitor multi-potentiality, and differentiation) and biomarkers predicting response will be presented, along with an outline for an upcoming clinical trial in former smokers.
Citation Format: Robert Keith.
Iloprost for lung cancer prevention [abstract].
In: Proceedings of the Second Biennial NCI Meeting: Translational Advances in Cancer Prevention Agent Development (TACPAD); 2022 Sep 7-9.
Philadelphia (PA): AACR; Can Prev Res 2022;15(12 Suppl_2): Abstract nr IA017.
Related Results
The application of prostacyclin in promoting angiogenesis of dental pulp tissue in a three dimensional organ culture system
The application of prostacyclin in promoting angiogenesis of dental pulp tissue in a three dimensional organ culture system
Background: Dental pulp vitality can be threatened by carious or iatrogenic exposure that can lead to pulp tissue loss. The formation of a vascular network is crucial to provide a ...
2D perfusion angiography as quantitative method to evaluate iloprost effect on foot circulation
2D perfusion angiography as quantitative method to evaluate iloprost effect on foot circulation
Summary: Background: Two-dimensional (2D) perfusion angiography is useful for the evaluation of foot perfusion in patients with critical limb-threatening ischemia (CLTI). Iloprost ...
Abstract SY38-02: Clinical investigations of obesity in cancer: BMI and other confounders
Abstract SY38-02: Clinical investigations of obesity in cancer: BMI and other confounders
Abstract
Obesity has been linked with increased incidence and worse outcomes of at least 13 human cancers. For other cancers, our understanding of their relationship...
Analysis of the Efficacy of Iloprost Treatment in Amputations Due to Burn
Analysis of the Efficacy of Iloprost Treatment in Amputations Due to Burn
Abstract
The aim of our study was to demonstrate the decrease in amputation rates with iloprost treatment in patients who develop vascular injury due to burns. The d...
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract 1345: Evidence for genetic mediation of lung cancer through hay fever.
Abstract
Introduction: In the past decade, advances in genetics have led to the discovery of numerous lung cancer susceptibility variants. The majority of these vari...
Abstract 1590: Robust evolutionary conservation and pair-wise co-mapping of polygenic colon and lung cancer susceptibility loci
Abstract 1590: Robust evolutionary conservation and pair-wise co-mapping of polygenic colon and lung cancer susceptibility loci
Abstract
Comparing chromosomal locations of statistically significant colon and lung cancer susceptibility loci detected by linkage in mouse and rat and by GWAS i...
The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1
The RNA demethylase ALKBH5 promotes the progression and angiogenesis of lung cancer by regulating the stability of the LncRNA PVT1
Abstract
Background
N6-methyladenosine (m6A) is the most common posttranscriptional modification of RNA and plays critical roles in human cancer pro...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...